REGIONAL HEALTH PROPERTIES, INC

RHEP
About the company

Regional Health Properties, Inc., through its subsidiaries, operates as a self-managed real estate investment company that invests primarily in real estate purposed for long-term care and senior living. Its business principally consists of leasing and subleasing such facilities to third-party tenants, which operate the facilities.

Country: United StatesPrice: $0.92Market Cap: $3.6M

Investment snapshot

24%positive consensus
Scored 1d ago

Positive

4

BUY / PASS

Neutral / negative

3 / 9

NEUTRAL / FAIL

Median fair value

$6.22

+578.3% vs price

Models with upside

5 / 17

Positive margin of safety

Strongest signal

Models split on RHEP at $0.92 — fair values range $0.67–$102.05

Key risk

11 of 12 flag RHEP's debt & leverage — Graham, Buffett, Lynch +8 more

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILFAIL · Rank #1623 (Top 52.4%)PASSFAILPASSNEUTRALFAILFAILFAILPASSPASSNEUTRALFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of Safety+37.6%+93.3%N/A-36.9%N/A+99.1%N/A+91.6%N/AN/AN/A+33.1%N/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Annual history · FY 2025

Latest source filing: 2026-08-12

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30

Latest source filing: 2026-08-12

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-06-30 · TTM ended 2026-06-30 vs 2025-06-30 · TTM ended 2026-06-30

Latest source filing: 2026-08-12

Score computed: 2026-11-14

TTM ended 2026-06-30

Latest source filing: 2026-08-12

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-04-02

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Market data at 2026-11-01

Latest source filing: 2026-08-12

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30

Latest source filing: 2026-08-12

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-04-02

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-06-30 · Balance sheet at 2026-06-30

Latest source filing: 2026-08-12

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30 · Qualitative assessment

Latest source filing: 2026-08-12

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Market data at 2026-11-01

Latest source filing: 2026-08-12

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-06-30

Latest source filing: 2026-08-12

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-04-02

Score computed: 2026-11-14

TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-08-12

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30

Latest source filing: 2026-08-12

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-06-30

Latest source filing: 2026-08-12

Score computed: 2026-11-14

TTM ended 2026-06-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-08-12

Score computed: 2026-11-14

Where It Passes

  • Valuation models83% pass✓ 5✗ 1▾

    Models split on RHEP at $0.92 — fair values range $0.67–$102.05

    Graham fair value$1.47
    ✓Graham+37.6% margin vs $0.92
    Buffett fair value$13.71
    ✓Buffett+93.3% margin vs $0.92
    Greenblatt fair value$0.67
    ✗Greenblatt-36.9% margin vs $0.92
    Dreman fair value$102.05
    ✓Dreman+99.1% margin vs $0.92
    Pabrai fair value$10.97
    ✓Pabrai+91.6% margin vs $0.92
    Templeton fair value$1.37
    ✓Templeton+33.1% margin vs $0.92

Where It Falls Short

  • Debt & Leverage8% pass✓ 1✗ 14▾

    11 of 12 flag RHEP's debt & leverage — Graham, Buffett, Lynch +8 more

    LT Debt vs Net Current AssetsLT Debt $34.1M vs NCA $-9.4M
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: N/A (negative equity), IC: 0.6x
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / EquityN/A (negative equity)
    ✗Lynch< 0.33
    Cash - Long-term Debt$-32.4M
    ✗LynchPositive preferred
    LT Debt / Total Assets Change64.97% -> 51.23%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities0.65
    ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity
    ✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00x
    Debt LevelsN/A (non-positive equity)
    ✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=0.6x, D/EBITDA=9.2x
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity
    ✗Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)
    ✗AsnessTop 30% of eligible cross-section
  • Growth13% pass✓ 3✗ 10▾

    7 of 8 flag RHEP's growth — Graham, Lynch, Dreman +4 more

    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)P/E 0.8x (growth N/A)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthInv: new vs Rev: 189.9%
    ✗LynchInventory growth < Revenue growth
    EPS Growth Direction
    ✗DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency4/18 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth6.8%
    ✓Ackman>= 5%
    Positive EPS Growth Frequency2/5 years with positive EPS growth
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendrevenue up, operating margin -4.8% -> 3.1%
    ✓SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR24.8%
    ✓SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
  • Efficiency13% pass✓ 2✗ 9▾

    7 of 8 flag RHEP's efficiency — Graham, Buffett, Greenblatt +4 more

    Current Ratio0.65
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)-0.7%
    ✗Buffett> 10%
    ROIC - WACC-10.7%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)5.3%
    ✗Greenblatt> 25%
    Current Ratio Change YoY0.33 -> 0.67
    ✓PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY0.30x -> 0.78x
    ✓PiotroskiImproved YoY
    Current Assets / Current Liabilities0.65
    ✗Dreman> 1.5
    Return on Invested Capital3.3%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=-1.3%; FY2024: ROIC=0.3%; FY2025: ROIC=3.2%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROIC3.2% (RR=100% x ROIC=3.2%)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/5 years above 12% (latest 3.2%)
    ✗SleepROIC > 12% in a majority of years
  • Profitability19% pass✓ 11✗ 24▾

    13 of 16 flag RHEP's profitability — Graham, Buffett, Lynch +10 more

    Positive EPS (10 years)2/19 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)4/19 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)-267.7%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)3.1% (latest)
    ✓BuffettStable or rising over 10 years
    Free Cash Flow Proxy$4.6M
    ✓BuffettPositive and growing
    Earnings Variance (10-yr CoV)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)P/E 0.8x (growth N/A)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROEN/A (negative equity)
    ✗Lynch> 15%
    EBIT / Enterprise Value3.8%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=3.8%, ROC=5.3%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets4.97%
    ✓PiotroskiROA > 0
    ROA Change YoY-5.32% -> 4.97% (delta: +10.29%)
    ✓PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=-3.33%, ROA=4.97%
    ✗PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY
    ✗PiotroskiImproved YoY
    Pre-Tax Income / Revenue
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity
    ✗Dreman> 12%
    Margin of SafetyP/E=0.8x, P/B=10.3x
    ✓PabraiP/B < 1.5 or P/E < 15
    Return on Equity-440.3% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic Value99.1% (IV=$102.05 vs Price=$0.92)
    ✓Marks>= 20% below intrinsic value
    Positive Net Income Frequency4/18 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue1.9%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity
    ✗Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend-4.8% (2023) -> 3.1% (2025)
    ✓TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendrevenue up, operating margin -4.8% -> 3.1%
    ✓SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization+113.06%; #91/6340 (top 1.4%)
    ✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets+68.10%; #361/3702 (top 9.8%)
    ✓AsnessTop 30% of eligible cross-section
    Net income / positive book equity
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.0511; #2614/5884 (top 44.4%)
    ✗AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years2/10 years positive
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Cash Flow20% pass✓ 2✗ 10▾

    8 of 10 flag RHEP's cash flow — Lynch, Piotroski, Dreman +5 more

    Free Cash Flow Proxy$4.6M
    ✓BuffettPositive and growing
    FCF Positive and Growing$-3.9M
    ✗LynchPositive and growing
    Operating Cash Flow$-2.3M
    ✗PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=-3.33%, ROA=4.97%
    ✗PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    P/E or FCF YieldP/E=0.8x, FCF Yield=-86.9%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive8/16 years FCF positive
    ✗MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap-109.2%
    ✗Ackman>= 4%
    Price / FCF per ShareN/A (negative FCF)
    ✗Ackman<= 25
    Positive Operating Cash Flow frequency10/16 years positive
    ✗SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$-3.9M
    ✗Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization-109.45%; #4090/4519 (top 90.5%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Valuation23% pass✓ 13✗ 15▾

    10 of 13 flag RHEP's valuation — Graham, Lynch, Greenblatt +7 more

    Price / 3-yr avg EPS0.1x
    ✓Graham<= 15x
    Price-to-Book Ratio10.3x
    ✗Graham<= 1.5x
    P/E x P/B1.40
    ✓Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)P/E 0.8x (growth N/A)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value3.8%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=3.8%, ROC=5.3%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS0.8x
    ✓Dreman< 12x✓Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    Price / Book Value per Share10.3x
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessP/E=0.8x, OE Yield=126.5%
    ✓MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldP/E=0.8x, FCF Yield=-86.9%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/E=0.8x, P/B=10.3x
    ✓MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic Value99.1% (IV=$102.05 vs Price=$0.92)
    ✓Marks>= 20% below intrinsic value
    Price / FCF per ShareN/A (negative FCF)
    ✗Ackman<= 25
    Price vs. Trailing Low100% of trailing low ($0.92)
    ✓Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization+113.06%; #91/6340 (top 1.4%)
    ✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization-0.4757; #5942/6449 (top 92.1%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS0.8x
    ✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per ShareN/A (non-positive TBVPS)
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change
    ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+22.6504; #198/5247 (top 3.8%)
    ✓OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization-109.45%; #4090/4519 (top 90.5%)
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-20.26%; #3982/6202 (top 64.2%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Verdicts29% pass✓ 4✗ 10▾

    Split decision: 9 FAIL · 4 PASS · 3 NEUTRAL

    Overall verdict
    ✗GrahamFAIL (2/9)✗BuffettFAIL (2/9)✗LynchFAIL (0/7)✗GreenblattRank #1623✓PiotroskiPASS (F-Score 5)✗DremanFAIL (1/11)✓MungerPASS (2/4)•PabraiNEUTRAL (2/3)✗AkreFAIL (1/6)✗MarksFAIL (2/5)✗AckmanFAIL (2/9)✓TempletonPASS (4/8)✓SleepPASS (3/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (2/6)✗SchlossFAIL (0/7)•OshaughnessyNEUTRAL (Not ranked)

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Real Estate
Size: Micro Cap($3.6M)
Revenue: $53.2M+189.9% YoY
Net Income: $3.4M+204.7% YoY

Financial Snapshot

Operating Margin3.1%
Return on Equity965.6%
Debt / Equity115.05
Current Ratio0.67
EPS (Diluted)$1.09
Buybacks (1y)$3.6M

Similar Companies

JLLJONES LANG LASALLE INC
$16.8B
FSVFirstService Corp
$6.5B
JOEST JOE Co
$4.0B
GTYGETTY REALTY CORP /MD/
$1.9B

Shareholder Return

Fiscal 2025

Share retirement not available for this company.

Buybacks
$3.6M
Dividends
—

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-09-30

2025-10-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, ebit, interest expense, operating cash flow, depreciation amortization, capex.

Q3 FY 2026

2026-07-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex.

Q2 FY 2026

2026-04-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex.

Q1 FY 2026

2026-01-01 – 2026-03-31

Sources
FY 2025
Sources
  • 10-K · 2026-04-02
FY 2024
Sources
  • 10-K · 2025-03-31
FY 2023
Sources
  • 10-K · 2024-04-01
FY 2022
Sources
  • 10-K · 2023-04-14
FY 2021
Sources
  • 10-K · 2022-02-22
Market Cap$3.6Mcurrent------$5.0Mest.$5.0Mest.$4.1Mest.$5.3Mest.$5.8Mest.
Revenue$91.4M↑140%$25.0M↑65%$24.4M↑143%$21.2M↑194%$53.2M↑190%$18.3M↑7%$17.2M↓52%$35.9M↑35%$26.7M
Operating Income$2.0M↑332%-$131.0K↑78%-$216.0K↑57%-$702.0K↓121%$1.7M↑934%$161.0K↑120%-$821.0K↑88%-$6.8M↓369%$2.5M
Net Income-$192.0K↓286%-$879.0K↓126%-$791.0K↑45%-$1.2M↑3%$3.4M↑205%-$3.2M↑17%-$3.9M↑43%-$6.9M↓481%-$1.2M
EPS (Diluted)--$-0.22↓119%$-0.20↑71%$-0.29↑69%$1.09↑163%$-1.73↓108%$21.05↑336%$-8.93↓52%$-5.87
Gross Margin————86.9%————
Operating Margin2.2%↑196%-0.5%↑87%-0.9%↑83%-3.3%↑25%3.1%↑256%0.9%↑118%-4.8%↑75%-19.0%↓300%9.5%
ROE7.4%↑210%———965.6%↑776%110.2%↑105%-2101.6%↓1037%-184.8%↓1525%-11.4%
Total Debt$39.2M↓19%$39.2M↓19%$39.5M↓19%$39.7M↓19%$40.2M↓3%$41.5M↓18%$50.7M↓3%$52.2M↓1%$52.9M
Shareholders' Equity-$2.6M↓70%-$2.6M↓70%-$1.7M↑69%-$962.0K↑77%$349.0K↑112%-$2.9M↓1678%$185.0K↓95%$3.7M↓64%$10.4M
Current Ratio0.640.640.650.640.67↑102%0.33———
Debt / Equity-15.01↑52%-15.01↑52%-23.07↓157%-41.25↓249%115.05↑909%-14.21↓105%274.24↑1853%14.04↑176%5.09
Operating Cash Flow$1.2M↑3100%$2.0M↑211%$1.4M↑144%-$890.0K↓477%-$2.3M↓216%$1.9M↓48%$3.7M↑203%-$3.6M↓173%$4.9M
Free Cash Flow-$564.0K↑28%$1.3M↑162%$889.0K↑224%-$1.3M↓833%-$3.1M↓321%$1.4M↓49%$2.8M↑171%-$3.9M↓181%$4.8M

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Real Estate

RHEP vs Peers — Financial Grading

Revenue$53.2MBottom 25%
Net Income$3.4MBottom 25%
ROE965.6%Top 25%
D/E115.05Bottom 25%
Op. Margin3.1%Bottom 25%
Curr. Ratio0.67Bottom 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
JONES LANG LASALLE INCJLL$16.8B$366.83$26.1B$792.1M10.6%0.124.2%1.112/92/93/71/3F-Score 83/11
FirstService CorpFSV$6.5B$154.42$5.5B$190.7M13.9%0.796.1%1.702/94/93/71/3F-Score 66/11
ST JOE CoJOE$4.0B$70.36$513.2M$115.6M15.1%0.5128.5%—1/92/94/70/3F-Score 84/11
GETTY REALTY CORP /MD/GTY$1.9B$28.66$221.7M$79.2M7.4%0.9357.2%—2/93/91/70/3F-Score 52/11
Ellington Financial Inc.EFC$1.5B$11.11—$118.7M6.5%———4/90/93/71/3F-Score 24/11
Piedmont Realty Trust, Inc.PDM$1.2B$10.00$565.0M$83.6M-5.6%1.4914.1%—2/92/91/70/3F-Score 32/11
IRSA INVESTMENTS & REPRESENTATIONS INCIRS$1.1B$12.54$394.6M$164.4M12.4%0.4136.8%1.661/90/91/71/3F-Score 55/11
CRESUD INCCRESY$690.8M$9.74$770.0M$81.0M4.3%0.61—1.241/90/91/73/3F-Score 43/11